Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Fulgent Genetics, Inc. - Common Stock
(NQ:
FLGT
)
15.28
-9.49 (-38.31%)
Streaming Delayed Price
Updated: 2:00 PM EST, Feb 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Fulgent Genetics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Which stocks are moving on Friday?
↗
Today 12:30 EST
Via
Chartmill
Gapping stocks in Friday's session
↗
Today 10:30 EST
Via
Chartmill
Fulgent Genetics (FLGT) Earnings Transcript
↗
Today 10:05 EST
Fulgent Genetics (FLGT) Earnings Transcript
Via
The Motley Fool
Topics
Artificial Intelligence
Fulgent Genetics (NASDAQ:FLGT) Shares Plunge on Weak 2026 Outlook After Mixed Q4
↗
Today 8:23 EST
Via
Chartmill
Fulgent Genetics's Earnings Outlook
↗
November 06, 2025
Via
Benzinga
Fulgent Genetics Earnings Preview
↗
July 31, 2025
Via
Benzinga
A Peek at Fulgent Genetics's Future Earnings
↗
May 01, 2025
Via
Benzinga
Fulgent Genetics (FLGT) Earnings Call Transcript
↗
November 27, 2025
Fulgent Genetics (FLGT) Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
FULGENT GENETICS INC (NASDAQ:FLGT) Beats Q3 2025 Earnings Estimates and Raises Guidance
↗
November 07, 2025
Fulgent Genetics Q3 2025 earnings beat expectations with a surprise profit, causing a 4% pre-market stock surge. The company also raised its full-year guidance.
Via
Chartmill
Topics
Earnings
Fulgent Genetics: A Risky Bet or a Hidden Gem?
↗
September 11, 2025
Fulgent Genetics has seen its fortunes shift since the pandemic. Is it a solid investment or a risky bet? Join us as we break down its performance and management decisions.
Via
The Motley Fool
Fulgent (FLGT) Q2 Revenue Jumps 16%
↗
August 02, 2025
Via
The Motley Fool
Why Fulgent Genetics Stock Was Crushing It on Friday
↗
August 01, 2025
The next-generation diagnostics specialist had a beat-and-raise second quarter.
Via
The Motley Fool
Uncovering Potential: Fulgent Genetics's Earnings Preview
↗
November 07, 2024
Via
Benzinga
Earnings Preview: Fulgent Genetics
↗
November 02, 2023
Via
Benzinga
Why Is Fulgent Genetics Stock Moving Higher Today?
↗
August 04, 2023
Fulgent Genetics Inc (NASDAQ: FLGT) reported Q2 sales of $68 million, beating the consensus estimate of $62.68 million.<
Via
Benzinga
Earnings Scheduled For November 7, 2025
↗
November 07, 2025
Via
Benzinga
Monolithic Power Systems, Workiva, Interface, AppFolio And Other Big Stocks Moving Higher On Friday
↗
August 01, 2025
Via
Benzinga
Earnings Outlook For Fulgent Genetics
↗
August 03, 2023
Via
Benzinga
These stocks that are showing activity before the opening bell on Friday.
↗
August 01, 2025
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
August 01, 2025
Via
Benzinga
Fulgent Genetics Revenue Tops Estimates
↗
February 28, 2025
Fulgent Genetics exceeded expectations in the fourth quarter of 2024, showcasing robust revenue growth and a GAAP loss.
Via
The Motley Fool
Earnings Scheduled For February 28, 2025
↗
February 28, 2025
Via
Benzinga
Earnings Scheduled For August 1, 2025
↗
August 01, 2025
Via
Benzinga
FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024
↗
May 03, 2024
FLGT stock results show that Fulgent Genetics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Earnings Scheduled For May 2, 2025
↗
May 02, 2025
Via
Benzinga
The 3 Best Digital Health Stocks for Personalized Medicine
↗
November 25, 2023
Digital health stocks are becoming increasingly relevant as more and more people seek greater control over their health.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
↗
September 29, 2023
Via
Benzinga
Earnings Scheduled For November 3, 2023
↗
November 03, 2023
Companies Reporting Before The Bell • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.
Via
Benzinga
Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist
↗
June 06, 2023
Fulgent is moving past its pandemic-era business, and that's a good thing.
Via
The Motley Fool
Earnings Scheduled For August 4, 2023
↗
August 04, 2023
Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first quarter. • Anglogold Ashanti (NYSE:AU) is likely to report earnings for its first quarter.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
